Tag: Pomerantz LLP

Vial + Syringe

Pending Litigation Shows Food Allergy Treatments in Development are Sometimes Overhyped

Drugs — sometimes touted as miracle treatments during development — don't necessarily pan out despite the hype.

Multiple Class Action Lawsuits Filed on Behalf of Shareholders Against Mylan

The actions are the result of a $465 million settlement the firm reached with the Justice Department regarding overcharging claims.